Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.

BACKGROUND: Drug-drug interactions (DDIs) are of major concern in oncology, since cancer patients typically take many concomitant medications. Retrospective studies have been conducted to determine the prevalence of DDIs. However, prospective studies on DDIs needing interventions in cancer patients have not yet been carried out. Therefore, a prospective study was designed to identify DDIs leading to interventions among ambulatory cancer patients receiving anticancer treatment. PATIENTS AND METHODS: Patients starting with a new treatment regimen with i.v. or oral anticancer medication were asked to participate. The patients' medication was checked for DDIs by using drug interaction software. An expert team of clinical pharmacologists evaluated the relevance of these identified DDIs. If a DDI was qualified as potentially clinically relevant, an intervention was proposed to the treating (hemato)oncologist. Several variables were studied as determinants for performing an intervention. Descriptive statistics and uni- and multivariate logistic regression analyses were carried out. RESULTS: In this study, 302 patients were included. A total of 603 DDIs were identified by the drug interaction software and judged by the expert team. Of all 603 DDIs, 120 DDIs were considered potentially clinically relevant. These 120 DDIs, present in a total of 81 patients, resulted in a clinical intervention already executed by the (hemato)oncologist in 39 patients (13%), while an additional intervention was proposed by a clinical pharmacologist in 42 patients (14%). The number of comorbidities and the number of 'over-the-counter' drugs were identified as determinants. CONCLUSIONS: Clinical interventions on DDIs are frequently required among patients starting with anticancer therapy. Structured screening for these potentially clinically relevant DDIs, by (hemato)oncologists in close collaborations with clinical pharmacologists, should take place before the start and during anticancer treatment. CLINICAL TRIALS NUMBER: This study was registered at the Dutch Trial Registry under number NTR3760.

Approaches for non-invasive assessment of endothelial function: focus on peripheral arterial tonometry.

The arterial endothelium is a complex organ that modulates vascular tone by release of various substances to control perfusion. Endothelial function reflects vascular ageing and health. Already at the earliest stages of atherosclerosis the delicate balance between arterial constriction and relaxation is disturbed. Therefore, non-invasive assessment of endothelial function is a means to identify patients at increased cardiovascular risk, even at levels of disease that cannot be identified with classical imaging techniques that depict arterial wall and/or lumen or with functional assessment of ischaemia. Currently, there is an increasing interest in the early recognition of endothelial dysfunction to streamline and optimise preventive therapeutic measures. In this article, several methods for the assessment of endothelial function are briefly reviewed. In particular, we discuss the fast bed-side assessment of endothelial function by the reactive hyperaemia peripheral arterial tonometry (RH-PAT) method.

[Aging and hyponutrition; a challenge for the sustainability of the NHS. Conclusions of the 9th ABBOT-SENPE Debate Forum]. / Envejecimiento y desnutrición; un reto para la sostenibilidad del SNS; conclusiones del IX Foro de Debate Abbott-SENPE.

Hyponutrition is a common problem at all health care levels, from primary to specialized care, as well as in geriatric care. Its incidence in a hospital setting is 40% and 60% in nursing homes. This is very important, it is highly related with progressive aging of the European population, and is the biggest and most frequent cause of disability among the elderly population living at home or institutions. Countries such as Holland, Denmark, or the United Kingdom have developed Comprehensive Strategic Plans to fight against hyponutrition by developing and implementing guidelines, establishing mandatory screenings at the moment of hospital admission and discharge, at nursing homes, etc. In our country, a combined action of SENPE and Abbott Foundation is developing a Comprehensive Strategic Plan (+ nutridos Project) in which clear, precise, and validated recommendations are established to perform nutritional screening both in hospitalized patients and institutionalized and ambulatory elderly people. This issue has to take into account the social and financial aspects. Hyponutrition is many times insufficiently recognized and treated. This has a negative impact on the individual patient in terms of morbidity, mortality, independence, and quality of life, as well as on the health care systems in terms of use of health care resources and costs.

[Do we understand Brussels? Risks and opportunities for the Netherlands' health care policy within the European Union]. / Begrijpen wij Brussel? Kansen en bedreigingen van de Nederlandse positiebepaling in de Europese Unie op het gebied van de gezondheidszorg.

Until recently, the European Union (EU) health agenda was limited to a selection of public health issues and good intentions of the Ministers of Health of the EU Member States. Lack of political will on the part of Member States to develop common policies in the fields of health care and social security is increasingly being bypassed by the political will and power of the European Parliament to initiate common action in these fields such as the Rocard report, for example, concerning the financing of health care. Furthermore, EU common market and other financial-economic regulations and policies already substantially affect the functioning of health care systems in Member States. The Netherlands' trade and professional associations should develop their organisation-specific EU strategies and policies as EU institutes, rules and culture substantially differ from national political and governmental systems; in recent years, the Dutch government has not always been successful in its approach and operations within the EU arena.

Right atrial tumor arising on an atrial septal aneurysm. Assessment by MR imaging.

An elderly women presenting with transient ischemic events underwent transesophageal echocardiography, which detected an aneurysm of the interatrial septum. A tumor protruding from the right atrial aspect of the aneurysm also was found incidentally. Not only was magnetic resonance (MRI) imaging helpful in better characterizing the aneurysm, but also the use of gadolinium diethylaminetriamine pentaacetic acid permitted differentiation between the tumor and adherent thrombus. To the best of our knowledge, this represents the first report of a tumor arising from an atrial septal aneurysm.

The use of intracoronary ultrasound for quantitative assessment of coronary artery lumen diameter and for on-line evaluation of angioplasty results.

UNLABELLED: The value of intracoronary ultrasound for quantitative assessment of minimal coronary arterial diameter and for on-line evaluation of balloon angioplasty result was studied in 42 patients undergoing single vessel coronary angioplasty. Measurement of minimal luminal diameter of 75 matched coronary arterial segments showed a significant correlation between both the ultrasound and angiographic method (r: 0.759; p < 0.001). Furthermore using intravascular ultrasound it was possible to classify the obtained coronary balloon angioplasty results. A preliminary correlation between ultrasound classification and the in-hospital acute rethrombosis as well as late restenosis was attempted in individual patients. CONCLUSIONS: 1) Clinical use of coronary ultrasound is feasible and safe in selected cases. 2) A significant correlation between intracoronary ultrasound and quantitative coronary angiography is demonstrated. 3) Using intracoronary ultrasound seems promising for evaluation of the postangioplasty result, and may finally lead to improved selection of the interventional strategy.